Seminal
The magazine and atlas of EU-funded researchA new publication from the web and AI team at Scott Charnley

Atlas / Netherlands

Coordination and Support Action · Running

ACT-PREP Advancing Clinical Trials and Epidemic Preparedness Research Capacity in Africa (act-prep)

Coordinator
European & Developing Countries Clinical Trials Partnership, Netherlands
Runs
1 June 2026 to 31 May 2031
Status
Running
EU funding
€12.8m
Total cost
—
Partners
14 organisations in 11 countries
Type
Coordination and Support Action
Grant agreement
101248971

What the project is doing

In the project's own words, from its summary on CORDIS.

Infectious diseases such as COVID-19 and Ebola are leading contributors to the high morbidity and mortality in sub-Saharan African (SSA), yet these countries have inadequate capacity to rapidly conduct clinical trials and other public research in preparedness and epidemic response. The ACT-PREP initiative seeks to enhance clinical research capacities for preparedness and response in SSA. With leadership from Makerere University School of Public Health, ACT-PREP will create a framework for equitable collaboration among 10 diverse African and 2 European institutions working closely with national public health institutes and Africa CDC to enhance disease surveillance, detection, and institutionalise research as a critical pillar of disease response.

ACT-PREP will strengthen capacities of partner institutions and actors in the research regulatory ecosystem and integrate the training into PhD and PostDoc training to reach more young researchers. ACT-PREP will promote sharing of expertise, experience, resources, datasets, and technology within and across countries to strengthen clinical research, ethics and regulatory capacities, and upgrade laboratory and surveillance systems across institutions and countries in SSA.

The research capacity enhancement will adapt a framework from our previous work between Makerere University and Karolinska Institute and the WHO Alliance for Health Policy and Systems Research framework. Additional strategies will include One health & AI systems to guide prediction, detection and rapid response to epidemics, and streamlined regulatory processes for timely clinical trial deployment and monitoring. This network will leverage immense in-kind resources from partners to train at least 100 fellows/other trainees annually, strengthen regional collaboration and capacity to conduct high quality trials, significantly advance epidemic preparedness and response and ultimately lower morbidity and mortality due to infectious diseases in SSA.

Who is involved

OrganisationCityCountryRole
European & Developing Countries Clinical Trials PartnershipDen HaagNetherlandsCoordinator
Universite De KinshasaKinshasaCDParticipant
Bernhard-Nocht-Institut Fuer TropenmedizinHamburgGermanyParticipant
Africa Centres for Disease Control and PreventionAddis AbabaETParticipant
University of Global Health Equity Ughe LtdKacyiruRWParticipant
Karolinska InstitutetStockholmSwedenParticipant
Universite Cheikh Anta Diop De DakarDakar FannSNParticipant
Somali National UniversityMogadishuSOParticipant
University of JubaJubaSSAssociatedpartner
Muhimbili University of Health and Allied SciencesDar Es SalaamTZParticipant
Infectious Diseases Research Collaboration Ltd by GuaranteeKampalaUGParticipant
Makerere UniversityKampalaUGParticipant
Makerere University Lung InstituteKampalaUGParticipant
Ministry of HealthKampalaUGParticipant

Source: CORDIS, European Commission. Data of 5 Nov 2026, reused under the Commission's reuse policy. View on CORDIS · Grant DOI